Takahiro Nakamoto

6PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 04, 2026
Distinct Prognostic Roles of Grade Group and Intraductal Carcinoma of the Prostate in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.

|Nov 25, 2025
HMGA2 links morphological evolution and microenvironment dynamics to systemic therapy response in clear cell renal cell carcinoma.

Takahiro Nakamoto, Takashi Yoshida, Chisato Ohe

|Nov 05, 2024
A case of mixed neuroendocrine carcinoma-acinar adenocarcinoma: Utilization of triplet therapy for prostate cancer.

Junichi Ikeda, Hisanori Taniguchi, Hiroki Takayama

|Jul 23, 2024
Impact of LAG-3/FGL1 pathway on immune evasive contexture and clinical outcomes in advanced urothelial carcinoma.

Takashi Yoshida, Takahiro Nakamoto, Naho Atsumi

|Jan 04, 2024
Re-salvage focal low-dose rate brachytherapy for local recurrence of prostate cancer after salvage focal low-dose rate brachytherapy.

Takahiro Nakamoto, Takashi Yoshida, Toshiko Shiga

Pageof 1

Frequent Collaborators

3 joint publications

Takashi Yoshida

2 joint publications

Junichi Ikeda

1 joint publications

Hisanori Taniguchi

1 joint publications

Yuki Masuo